Company Profile

Five Eleven Pharma Inc
Profile last edited on: 1/19/21      CAGE: 77KQ4      UEI: PJUGJJT3FLM5

Business Identifier: Novel radiotracer Ga P to facilitate Positron Emission Tomography PET detection of bone cancer
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3700 Market Street Suite 305
Philadelphia, PA 19104
   (215) 662-3989
Location: Single
Congr. District: 03
County: Philadelphia

Public Profile

With close ties to University of Pennsylvania - facilities used and personnel identified on several issued patents - published literature indicates Five Eleven Pharma to be "self-funding" two Phase I clinical trials to determine human dosimetry and pharmacokinetics in cancer patients using. Preliminary data from these trials it is indicated has shown a good safety profile, favorable dosimetry and accumulation of a critical PSMA-expressing tissue and prostate cancer lesions. Overall, however, the firm has a limited digital footprint

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  David Alexoff -- CEO

Company News

There are no news available.